{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T22:52:52Z","timestamp":1782600772473,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["721577"],"award-info":[{"award-number":["721577"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcopenia is the age-related loss of muscle mass and strength. Undiagnosed late-onset neuromuscular disorders need to be considered in the differential diagnosis of sarcopenia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Based on emblematic case reports and current neuromuscular diagnostic guidelines for three common late-onset neuromuscular disorders, a differential diagnostic approach for geriatric patients presenting with a sarcopenic phenotype is given.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients over 65\u00a0years of age with sarcopenia, amyotrophic lateral sclerosis, inclusion body myositis and myotonic dystrophy type 2 were recruited. All patients were assessed for sarcopenia based on the revised European consensus definition. Patients with neuromuscular diseases were diagnosed according to the revised El Escorial criteria and the European neuromuscular centre criteria. Phenotypes and diagnostic criteria for all patients were summarized including their specific histopathological findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All patients with neuromuscular diseases were positively screened for sarcopenia and classified as severe sarcopenic by means of assessment. The clinical phenotype, the evolution pattern of weakness and muscle atrophy combined with laboratory finding including electromyography could unquestionably distinguish the diseases.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Neuromuscular disorders can manifest beyond the age of 65\u00a0years and misdiagnosed as sarcopenia. The most common diseases are inclusion body myositis, amyotrophic lateral sclerosis and myotonic dystrophy type 2. A diagnostic work-up for neuromuscular diseases ensures their correct diagnosis by clinical-, electrophysiological, histopathological, and genetic work-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In geriatric patients with a focal or asymmetrical muscular weakness and atrophy, sarcopenia assessment should be extended with patient\u2019s history of disease course. Furthermore, concomitant diseases, analysis of serum creatine kinase, electrophysiological examination, and in selected patients muscle biopsy and gene analysis is needed to rule out a late-onset neuromuscular disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-021-02264-y","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:02:55Z","timestamp":1624593775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Late-onset neuromuscular disorders in the differential diagnosis of sarcopenia"],"prefix":"10.1186","volume":"21","author":[{"given":"Fabian","family":"Hofmeister","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Baber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hintze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Jarmusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Meinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Mehaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Neuerburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Tangenelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6709-9672","authenticated-orcid":false,"given":"Michael","family":"Drey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"2264_CR1","doi-asserted-by":"crossref","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Oirie YVESB, Ruy\u00e8re OLB, In SA, et al. Sarcopenia\u202f: revised European consensus on definition and diagnosis. Age Ageing. 2019;48 September 2018:16\u201331.","DOI":"10.1093\/ageing\/afz046"},{"key":"2264_CR2","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s00198-017-4027-y","volume":"28","author":"A Phillips","year":"2017","unstructured":"Phillips A, Strobl R, Vogt S, et al. Sarcopenia is associated with disability status\u2014results from the KORA-Age study. Osteoporos Int. 2017;28:2069\u201379.","journal-title":"Osteoporos Int"},{"key":"2264_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2049-3258-72-45","volume":"72","author":"C Beaudart","year":"2014","unstructured":"Beaudart C, Rizzoli R, Bruy\u00e8re O, Reginster J-Y, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72:45.","journal-title":"Arch Public Health"},{"key":"2264_CR4","first-page":"237","volume":"32","author":"MM Dimachkie","year":"2012","unstructured":"Dimachkie MM, M.D. and Richard J. . Barohn MD. Inclusion Body Myositis Semin Neurol. 2012;32:237\u201345.","journal-title":"Inclusion Body Myositis Semin Neurol"},{"issue":"7\u20138","key":"2264_CR5","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1080\/21678421.2018.1510010","volume":"19","author":"MO Santos","year":"2018","unstructured":"Santos MO, Gromicho M, Pinto S, De M. Very late-onset amyotrophic lateral sclerosis in a Portuguese cohort. Amyotroph Lateral Scler Front Degener. 2018;19(7\u20138):619\u201322.","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"2264_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.nmd.2006.03.010","volume":"16","author":"B Udd","year":"2006","unstructured":"Udd B, Meola G, Krahe R, Thornton C, Ranum LPW, Bassez G, et al. 140th ENMC International Workshop: Myotonic Dystrophy DM2\/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord. 2006;16:403\u201313.","journal-title":"Neuromuscul Disord"},{"key":"2264_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash MMT. El Escorial rivisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyothrop Lateral Scler Other Mot Neuron Disord. 2000;1:293\u20139.","journal-title":"Amyothrop Lateral Scler Other Mot Neuron Disord"},{"key":"2264_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.nmd.2013.08.007","volume":"23","author":"MR Rose","year":"2013","unstructured":"Rose MR. 188th ENMC International Workshop: Inclusion Body Myositis, 2\u20134 December 2011, Naarden. The Netherlands Neuromuscul Disord. 2013;23:1044\u201355.","journal-title":"The Netherlands Neuromuscul Disord"},{"key":"2264_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nmd.2011.03.013","volume":"21","author":"B Udd","year":"2011","unstructured":"Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, et al. Myotonic dystrophy type 2 ( DM2) and related disorders Report of the 180th ENMC Workshop including guidelines on diagnostics and management 3\u20135 December 2010, Naarden. The Netherlands Neuromuscul Disord. 2011;21:443\u201350.","journal-title":"The Netherlands Neuromuscul Disord"},{"key":"2264_CR10","doi-asserted-by":"crossref","unstructured":"Tanganelli F, Meinke P, Hofmeister F, Jarmusch S, Baber L. Type-2 Muscle Fiber Atrophy is Associated with Sarcopenia in Elderly Men with Hip Fracture. Exp Gerontol. 2020.","DOI":"10.1016\/j.exger.2020.111171"},{"key":"2264_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown RH, Al-Chalabi A. Amyotrophic Lateral Sclerosis. N Engl J Med. 2017;377:162\u201372.","journal-title":"N Engl J Med"},{"key":"2264_CR12","doi-asserted-by":"publisher","unstructured":"Tai H, Cui L, Guan Y, Liu M, Li X, Shen D, et al. Correlation of Creatine Kinase Levels with Clinical Features and Survival in Amyotrophic Lateral Sclerosis. Front Neurol. 2017;8 JUL:1\u20135. doi:https:\/\/doi.org\/10.3389\/fneur.2017.00322.","DOI":"10.3389\/fneur.2017.00322"},{"key":"2264_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen B, Robberecht W. The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol. 2014;10:661\u201370.","journal-title":"Nat Rev Neurol"},{"key":"2264_CR14","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.clinph.2020.04.005","volume":"131","author":"JM Shefner","year":"2020","unstructured":"Shefner JM, Al-chalabi A, Baker MR, Cui L, De CM, Eisen A, et al. A Proposal for New Diagnostic Criteria for ALS. Clin Neurophysiol. 2020;131:1975\u20138.","journal-title":"Clin Neurophysiol"},{"key":"2264_CR15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.pmr.2012.06.006","volume":"23","author":"NC Joyce","year":"2012","unstructured":"Joyce NC, Jin L. Muscle Biopsy Evaluation in Neuromuscular Disorders. Phys Med Rehabil Clin N Am. 2012;23:609\u201331.","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"2264_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1122-5","volume":"14","author":"N Suzuki","year":"2019","unstructured":"Suzuki N, Mori-yoshimura M, Yamashita S, Nakano S, Murata K, Mori M, et al. The updated retrospective questionnaire study of sporadic inclusion body myositis in Japan. Orphanet J Rare Dis. 2019;14:1\u20139.","journal-title":"Orphanet J Rare Dis"},{"key":"2264_CR17","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3945\/ajcn.113.068122","volume":"99","author":"JE Winter","year":"2014","unstructured":"Winter JE, Macinnis RJ, Wattanapenpaiboon N, Nowson CA. BMI and all-cause mortality in older adults\u202f: a meta-analysis. Am J Clin Nutr. 2014;99:875\u201390.","journal-title":"Am J Clin Nutr"},{"key":"2264_CR18","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s10072-019-03763-0","volume":"40","author":"S Peric","year":"2019","unstructured":"Peric S, Bozovic I, Nisic T, Banovic M, Vujnic M, Svabic T, et al. Body composition analysis in patients with myotonic dystrophy types 1 and 2. Neurol Sci. 2019;40:1035\u201340.","journal-title":"Neurol Sci"},{"key":"2264_CR19","doi-asserted-by":"crossref","unstructured":"Montagnese F, Mondello S, Wenninger S, Kress W, Schoser B. Assessing the influence of age and gender on the phenotype of myotonic dystrophy type 2. J Neurol. 2017;264.","DOI":"10.1007\/s00415-017-8653-2"},{"key":"2264_CR20","unstructured":"Sergi G, Rui M De, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living Caucasian older adults. Clin Nutr. 2014;:1\u20137."},{"key":"2264_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jamda.2013.05.018","volume":"14","author":"TK Malmstrom","year":"2013","unstructured":"Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc. 2013;14:531\u20132. https:\/\/doi.org\/10.1016\/j.jamda.2013.05.018.","journal-title":"J Am Med Dir Assoc"},{"key":"2264_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1097\/01.NAJ.0000314810.46029.74","volume":"108","author":"C Graf","year":"2008","unstructured":"Graf C. The Lawton instrumental Activities of Daily Living (IADL) Scale. Am J Nurs. 2008;108:52\u201362.","journal-title":"Am J Nurs"},{"key":"2264_CR23","doi-asserted-by":"publisher","first-page":"M366","DOI":"10.1093\/gerona\/56.6.M366","volume":"56","author":"LZ Rubenstein","year":"2001","unstructured":"Rubenstein LZ, Harker JO, Salva A, Guigoz Y, Vellas B. Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF). Journals Gerontol Ser A Biol Sci Med Sci. 2001;56:M366\u201372. https:\/\/doi.org\/10.1093\/gerona\/56.6.M366.","journal-title":"Journals Gerontol Ser A Biol Sci Med Sci"},{"key":"2264_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nmd.2010.05.003","volume":"20","author":"A Echaniz-Laguna","year":"2010","unstructured":"Echaniz-Laguna A, Mohr M, Lannes B, Tranchant C. Myopathies in the elderly: A hospital-based study. Neuromuscul Disord. 2010;20:443\u20137. https:\/\/doi.org\/10.1016\/j.nmd.2010.05.003.","journal-title":"Neuromuscul Disord"},{"key":"2264_CR25","doi-asserted-by":"publisher","unstructured":"Van den Berg-Vos RM, Visser J, Kalmijn S, Fischer K, de Visser M, de Jong V, et al. A Long-term Prospective Study of the Natural Course of Sporadic Adult-Onset Lower Motor Neuron Syndromes. Arch Neurol. 2009;66. doi:https:\/\/doi.org\/10.1001\/archneurol.2009.91.","DOI":"10.1001\/archneurol.2009.91"},{"key":"2264_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/BOR.0000000000000436","volume":"29","author":"K Schmidt","year":"2017","unstructured":"Schmidt K, Schmidt J. Inclusion body myositis: Advancements in diagnosis, pathomechanisms, and treatment. Curr Opin Rheumatol. 2017;29:632\u20138.","journal-title":"Curr Opin Rheumatol"},{"key":"2264_CR27","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","volume":"5","author":"JE Morley","year":"2014","unstructured":"Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology\u2014update 2014. J Cachexia Sarcopenia Muscle. 2014;5:253\u20139.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"2264_CR28","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/gerona\/57.6.M378","volume":"57","author":"\u00d2 Mir\u00f3","year":"2002","unstructured":"Mir\u00f3 \u00d2, Perea M, Pic\u00f3n M. Muscle Diseases in Elders\u202f: A 10-Year Retrospective Study. J Gerontol Med Sci. 2002;57:378\u201384.","journal-title":"J Gerontol Med Sci"},{"key":"2264_CR29","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1038\/oby.2004.250","volume":"12","author":"RN Baumgartner","year":"2004","unstructured":"Baumgartner RN, Wayne SJ, Waters DL, Janssen I, Gallagher D, Morley JE, et al. Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly. Obes Res. 2004;12:1996\u20132004.","journal-title":"Obes Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-021-02264-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-021-02264-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T04:03:36Z","timestamp":1624593816000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-021-02264-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2264"],"URL":"https:\/\/doi.org\/10.1186\/s12883-021-02264-y","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee, which belongs to the medical faculty of LMU Munich (IRB-No. 328\u201315). All patients gave their consent to participate. All participants gave written informed consent before enrolment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"241"}}